1. Home
  2. BYD vs CRSP Comparison

BYD vs CRSP Comparison

Compare BYD & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boyd Gaming Corporation

BYD

Boyd Gaming Corporation

HOLD

Current Price

$71.27

Market Cap

5.7B

ML Signal

HOLD

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$54.42

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYD
CRSP
Founded
1973
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.8B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
BYD
CRSP
Price
$71.27
$54.42
Analyst Decision
Hold
Buy
Analyst Count
11
17
Target Price
★ $90.82
$70.29
AVG Volume (30 Days)
857.2K
★ 1.4M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
★ 0.93%
N/A
EPS Growth
★ 264.46
N/A
EPS
★ 3.12
N/A
Revenue
★ $2,626,730,000.00
$289,590,000.00
Revenue This Year
$1.71
$807.72
Revenue Next Year
$2.74
$172.52
P/E Ratio
$23.03
★ N/A
Revenue Growth
9.41
★ 9169.85
52 Week Low
$69.90
$44.12
52 Week High
$91.41
$78.48

Technical Indicators

Market Signals
Indicator
BYD
CRSP
Relative Strength Index (RSI) 22.69 48.20
Support Level N/A $50.56
Resistance Level $90.37 $59.59
Average True Range (ATR) 1.67 2.72
MACD -0.22 0.01
Stochastic Oscillator 17.04 36.01

Price Performance

Historical Comparison
BYD
CRSP

About BYD Boyd Gaming Corporation

Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. The Midwest and South hold the key number of entertainment properties and generate the majority of the company's revenue.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: